-
1
-
-
0036310181
-
A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica
-
Lucchinetti CF, Mandler RN, McGavern D, et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain. 2002;125(pt 7):1450-1461. (Pubitemid 34755161)
-
(2002)
Brain
, vol.125
, Issue.7
, pp. 1450-1461
-
-
Lucchinetti, C.F.1
Mandler, R.N.2
McGavern, D.3
Bruck, W.4
Gleich, G.5
Ransohoff, R.M.6
Trebst, C.7
Weinshenker, B.8
Wingerchuk, D.9
Parisi, J.E.10
Lassmann, H.11
-
2
-
-
34547791832
-
The spectrum of neuromyelitis optica
-
DOI 10.1016/S1474-4422(07)70216-8, PII S1474442207702168
-
Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG. The spectrum of neuromyelitis optica. Lancet Neurol. 2007;6(9):805-815. (Pubitemid 47238676)
-
(2007)
Lancet Neurology
, vol.6
, Issue.9
, pp. 805-815
-
-
Wingerchuk, D.M.1
Lennon, V.A.2
Lucchinetti, C.F.3
Pittock, S.J.4
Weinshenker, B.G.5
-
3
-
-
77950881518
-
Different responses to interferon beta-1b treatment in patients with neuromyelitis optica and multiple sclerosis
-
Uzawa A, Mori M, Hayakawa S, Masuda S, Kuwabara S. Different responses to interferon beta-1b treatment in patients with neuromyelitis optica and multiple sclerosis. Eur J Neurol. 2010;17(5):672-676.
-
(2010)
Eur J Neurol
, vol.17
, Issue.5
, pp. 672-676
-
-
Uzawa, A.1
Mori, M.2
Hayakawa, S.3
Masuda, S.4
Kuwabara, S.5
-
4
-
-
75649107856
-
B-cell activating factor of the TNF family is upregulated in neuromyelitis optica
-
Okada K, Matsushita T, Kira J, Tsuji S. B-cell activating factor of the TNF family is upregulated in neuromyelitis optica. Neurology. 2010;74(2):177-178.
-
(2010)
Neurology
, vol.74
, Issue.2
, pp. 177-178
-
-
Okada, K.1
Matsushita, T.2
Kira, J.3
Tsuji, S.4
-
5
-
-
16844366404
-
An open label study of the effects of rituximab in neuromyelitis optica
-
Cree BA, Lamb S, Morgan K, Chen A, Waubant E, Genain C. An open label study of the effects of rituximab in neuromyelitis optica. Neurology. 2005;64(7):1270-1272.
-
(2005)
Neurology
, vol.64
, Issue.7
, pp. 1270-1272
-
-
Cree, B.A.1
Lamb, S.2
Morgan, K.3
Chen, A.4
Waubant, E.5
Genain, C.6
-
6
-
-
0031665071
-
Devic's neuromyelitis optica: A prospective study of seven patients treated with prednisone and azathioprine
-
Mandler RN, Ahmed W, Dencoff JE. Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine. Neurology. 1998;51(4):1219-1220. (Pubitemid 28473439)
-
(1998)
Neurology
, vol.51
, Issue.4
, pp. 1219-1220
-
-
Mandler, R.N.1
Ahmed, W.2
Dencoff, J.E.3
-
7
-
-
34247093688
-
Immunosuppressive therapy is more effective than interferon in neuromyelitis optica
-
DOI 10.1177/1352458506070732
-
Papeix C, Vidal JS, de Seze J, et al. Immunosuppressive therapy is more effective than interferon in neuromyelitis optica. Mult Scler. 2007;13(2):256-259. (Pubitemid 46592781)
-
(2007)
Multiple Sclerosis
, vol.13
, Issue.2
, pp. 256-259
-
-
Papeix, C.1
Vidal, J.-S.2
De Seze, J.3
Pierrot-Deseilligny, C.4
Tourbah, A.5
Stankoff, B.6
Lebrun, C.7
Moreau, T.8
Vermersch, P.9
Fontaine, B.10
Lyon-Caen, O.11
Gout, O.12
-
8
-
-
55949127730
-
Treatment of neuromyelitis optica with rituximab: Retrospective analysis of 25 patients
-
Jacob A, Weinshenker BG, Violich I, et al. Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients. Arch Neurol. 2008;65(11):1443-1448.
-
(2008)
Arch Neurol
, vol.65
, Issue.11
, pp. 1443-1448
-
-
Jacob, A.1
Weinshenker, B.G.2
Violich, I.3
-
9
-
-
70349150578
-
Treatment of neuromyelitis optica with mycophenolate mofetil: Retrospective analysis of 24 patients
-
Jacob A, Matiello M, Weinshenker BG, et al. Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients. Arch Neurol. 2009;66(9):1128-1133.
-
(2009)
Arch Neurol
, vol.66
, Issue.9
, pp. 1128-1133
-
-
Jacob, A.1
Matiello, M.2
Weinshenker, B.G.3
-
10
-
-
33745858352
-
Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (Devic disease)
-
DOI 10.1001/archneur.63.7.957
-
Weinstock-Guttman B, Ramanathan M, Lincoff N, et al. Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (Devic disease). Arch Neurol. 2006;63(7):957-963. (Pubitemid 44036296)
-
(2006)
Archives of Neurology
, vol.63
, Issue.7
, pp. 957-963
-
-
Weinstock-Guttman, B.1
Ramanathan, M.2
Lincoff, N.3
Napoli, S.Q.4
Sharma, J.5
Feichter, J.6
Bakshi, R.7
-
11
-
-
20444434782
-
Multiple sclerosis: Mitoxantrone promotes differential effects on immunocompetent cells in vitro
-
DOI 10.1016/j.jneuroim.2005.01.024, PII S016557280500367X
-
Neuhaus O, Wiendl H, Kieseier BC, et al. Multiple sclerosis: mitoxantrone promotes differential effects on immunocompetent cells in vitro. J Neuroimmunol. 2005;168(1-2):128-137. (Pubitemid 41396410)
-
(2005)
Journal of Neuroimmunology
, vol.168
, Issue.1-2
, pp. 128-137
-
-
Neuhaus, O.1
Wiendl, H.2
Kieseier, B.C.3
Archelos, J.J.4
Hemmer, B.5
Stuve, O.6
Hartung, H.-P.7
-
12
-
-
11244349904
-
Mitoxantrone induces cell death in peripheral blood leucocytes of multiple sclerosis patients
-
DOI 10.1111/j.1365-2249.2005.02653.x
-
Chan A, Weilbach FX, Toyka KV, Gold R. Mitoxantrone induces cell death in peripheral blood leucocytes of multiple sclerosis patients. Clin Exp Immunol. 2005;139(1):152-158. (Pubitemid 40066141)
-
(2005)
Clinical and Experimental Immunology
, vol.139
, Issue.1
, pp. 152-158
-
-
Chan, A.1
Weilbach, F.X.2
Toyka, K.V.3
Gold, R.4
-
13
-
-
34248230257
-
Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis
-
Duddy M, Niino M, Adatia F, et al. Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis. J Immunol. 2007;178(10):6092-6099. (Pubitemid 46717389)
-
(2007)
Journal of Immunology
, vol.178
, Issue.10
, pp. 6092-6099
-
-
Duddy, M.1
Niino, M.2
Adatia, F.3
Hebert, S.4
Freedman, M.5
Atkins, H.6
Ho, J.K.7
Bar-Or, A.8
-
14
-
-
33745334334
-
Revised diagnostic criteria for neuromyelitis optica
-
DOI 10.1212/01.wnl.0000216139.44259.74, PII 0000611420060523000008
-
Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006;66(10):1485-1489. (Pubitemid 43958540)
-
(2006)
Neurology
, vol.66
, Issue.10
, pp. 1485-1489
-
-
Wingerchuk, D.M.1
Lennon, V.A.2
Pittock, S.J.3
Lucchinetti, C.F.4
Weinshenker, B.G.5
-
15
-
-
0026018422
-
DNA strand breakage by peroxidase-activated mitoxantrone
-
Fisher GR, Patterson LH. DNA strand breakage by peroxidase-activated mitoxantrone. J Pharm Pharmacol. 1991;43(1):65-68.
-
(1991)
J Pharm Pharmacol
, vol.43
, Issue.1
, pp. 65-68
-
-
Fisher, G.R.1
Patterson, L.H.2
-
16
-
-
0029121860
-
Topoisomerase II DNA cleavage stimulation, DNA binding activity, cytotoxicity, and physico-chemical properties of 2-aza-and 2-aza-oxide- anthracenedione derivatives
-
De Isabella P, Palumbo M, Sissi C, et al. Topoisomerase II DNA cleavage stimulation, DNA binding activity, cytotoxicity, and physico-chemical properties of 2-aza-and 2-aza-oxide-anthracenedione derivatives. Mol Pharmacol. 1995;48(1):30-38.
-
(1995)
Mol Pharmacol
, vol.48
, Issue.1
, pp. 30-38
-
-
De Isabella, P.1
Palumbo, M.2
Sissi, C.3
-
17
-
-
0027333102
-
Various inhibitors of DNA topoisomerases diminish repair-specific DNA incision in UV-irradiated human fibroblasts
-
Thielmann HW, Popanda O, Gersbach H, Gilberg F. Various inhibitors of DNA topoisomerases diminish repair-specific DNA incision in UV-irradiated human fibroblasts. Carcinogenesis. 1993;14(11):2341-2351. (Pubitemid 23335192)
-
(1993)
Carcinogenesis
, vol.14
, Issue.11
, pp. 2341-2351
-
-
Thielmann, H.W.1
Popanda, O.2
Gersbach, H.3
Gilberg, F.4
-
18
-
-
33751010179
-
Inhibition by mitoxantrone of in vitro migration of immunocompetent cells: A possible mechanism for therapeutic efficacy in the treatment of multiple sclerosis
-
DOI 10.1001/archneur.63.11.1572
-
Kopadze T, Dehmel T, Hartung HP, Stüve O, Kieseier BC. Inhibition by mitoxantrone of in vitro migration of immunocompetent cells: a possible mechanism for therapeutic efficacy in the treatment of multiple sclerosis. Arch Neurol. 2006;63(11):1572-1578. (Pubitemid 44748799)
-
(2006)
Archives of Neurology
, vol.63
, Issue.11
, pp. 1572-1578
-
-
Kopadze, T.1
Dehmel, T.2
Hartung, H.-P.3
Stuve, O.4
Kieseier, B.C.5
-
19
-
-
10944231932
-
Mechanism of action of mitoxantrone
-
Fox EJ. Mechanism of action of mitoxantrone. Neurology. 2004;63(12)(suppl 6): S15-S18. (Pubitemid 40019273)
-
(2004)
Neurology
, vol.63
, Issue.12 SUPPL. 6
-
-
Fox, E.J.1
-
20
-
-
0022450390
-
Selective immunomodulation by the antineoplastic agent mitoxantrone. I. Suppression of B lymphocyte function
-
Fidler JM, DeJoy SQ, Gibbons JJ Jr. Selective immunomodulation by the antineoplastic agent mitoxantrone I: suppression of B lymphocyte function. J Immunol. 1986;137(2):727-732. (Pubitemid 16045109)
-
(1986)
Journal of Immunology
, vol.137
, Issue.2
, pp. 727-732
-
-
Fidler, J.M.1
DeJoy, S.Q.2
Gibbons Jr., J.J.3
-
21
-
-
0026010353
-
Suppression of demyelination by mitoxantrone
-
Watson CM, Davison AN, Baker D, O'Neill JK, Turk JL. Suppression of demyelination by mitoxantrone. Int J Immunopharmacol. 1991;13(7):923-930.
-
(1991)
Int J Immunopharmacol
, vol.13
, Issue.7
, pp. 923-930
-
-
Watson, C.M.1
Davison, A.N.2
Baker, D.3
O'Neill, J.K.4
Turk, J.L.5
-
22
-
-
70349411720
-
Efficacy and safety of mitoxantrone, as an initial therapy, in multiple sclerosis: Experience in an Indian tertiary care setting
-
Singhal BS, Geeta S, Hundalani SG, Menon S. Efficacy and safety of mitoxantrone, as an initial therapy, in multiple sclerosis: experience in an Indian tertiary care setting. Neurol India. 2009;57(4):418-423.
-
(2009)
Neurol India
, vol.57
, Issue.4
, pp. 418-423
-
-
Singhal, B.S.1
Geeta, S.2
Hundalani, S.G.3
Menon, S.4
-
23
-
-
10944233139
-
Mitoxantrone treatment of multiple sclerosis: Safety considerations
-
Cohen BA, Mikol DD. Mitoxantrone treatment of multiple sclerosis: safety considerations. Neurology. 2004;63(12)(suppl 6):S28-S32. (Pubitemid 40019276)
-
(2004)
Neurology
, vol.63
, Issue.12 SUPPL. 6
-
-
Cohen, B.A.1
Mikol, D.D.2
-
24
-
-
77951828930
-
Evidence report: The efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
-
Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
-
Marriott JJ, Miyasaki JM, Gronseth G, O'Connor PW; Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Evidence report: the efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2010;74(18):1463-1470.
-
(2010)
Neurology
, vol.74
, Issue.18
, pp. 1463-1470
-
-
Marriott, J.J.1
Miyasaki, J.M.2
Gronseth, G.3
O'Connor, P.W.4
-
25
-
-
63449128972
-
Therapy-related acute leukaemia with mitoxantrone: What is the risk and can we minimise it?
-
Ellis R, Boggild M. Therapy-related acute leukaemia with mitoxantrone: what is the risk and can we minimise it? Mult Scler. 2009;15(4):505-508.
-
(2009)
Mult Scler
, vol.15
, Issue.4
, pp. 505-508
-
-
Ellis, R.1
Boggild, M.2
-
26
-
-
0038579530
-
Effect of regression to the mean on decision making in health care
-
Morton V, Torgerson DJ. Effect of regression to the mean on decision making in health care. BMJ. 2003;326(7398):1083-1084. (Pubitemid 36629731)
-
(2003)
British Medical Journal
, vol.326
, Issue.7398
, pp. 1083-1084
-
-
Morton, V.1
Torgerson, D.J.2
-
27
-
-
37749016994
-
Mitoxantrone as induction treatment in aggressive relapsing remitting multiple sclerosis: Treatment response factors in a 5 year follow-up observational study of 100 consecutive patients
-
Le Page E, Leray E, Taurin G, et al. Mitoxantrone as induction treatment in aggressive relapsing remitting multiple sclerosis: treatment response factors in a 5 year follow-up observational study of 100 consecutive patients. J Neurol Neurosurg Psychiatry. 2008;79(1):52-56.
-
(2008)
J Neurol Neurosurg Psychiatry
, vol.79
, Issue.1
, pp. 52-56
-
-
Le Page, E.1
Leray, E.2
Taurin, G.3
-
28
-
-
59249089860
-
Concepts of induction and escalation therapy in multiple sclerosis
-
Rieckmann P. Concepts of induction and escalation therapy in multiple sclerosis. J Neurol Sci. 2009;277(suppl 1):S42-S45.
-
(2009)
J Neurol Sci
, vol.277
, Issue.SUPPL. 1
-
-
Rieckmann, P.1
-
29
-
-
59249103269
-
Immunosuppression followed by immunomodulation
-
Boggild M. Immunosuppression followed by immunomodulation. J Neurol Sci. 2009;277(suppl 1):S50-S54.
-
(2009)
J Neurol Sci
, vol.277
, Issue.SUPPL. 1
-
-
Boggild, M.1
-
30
-
-
46849091551
-
Glatiramer acetate after induction therapy with mitoxantrone in relapsing multiple sclerosis
-
DOI 10.1177/1352458507085759
-
Vollmer T, Panitch H, Bar-Or A, et al. Glatiramer acetate after induction therapy with mitoxantrone in relapsing multiple sclerosis. Mult Scler. 2008;14(5):663-670. (Pubitemid 351954409)
-
(2008)
Multiple Sclerosis
, vol.14
, Issue.5
, pp. 663-670
-
-
Vollmer, T.1
Panitch, H.2
Bar-Or, A.3
Dunn, J.4
Freedman, M.S.5
Gazda, S.K.6
Campagnolo, D.7
Deutsch, F.8
Arnold, D.L.9
|